| Characterization and comparison of human glioblastoma models JA Schulz, LT Rodgers, RJ Kryscio, AMS Hartz, B Bauer BMC cancer 22 (1), 844, 2022 | 35 | 2022 |
| Isolation of cerebral capillaries from fresh human brain tissue AMS Hartz, JA Schulz, BS Sokola, SE Edelmann, AN Shen, RG Rempe, ... Journal of visualized experiments: JoVE, 57346, 2018 | 32 | 2018 |
| ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery JA Schulz, AMS Hartz, B Bauer Pharmacological Reviews 75 (5), 815-853, 2023 | 31 | 2023 |
| Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review JA Schulz, DM Stresser, JC Kalvass Drug Metabolism Reviews 55 (3), 205-238, 2023 | 24 | 2023 |
| Drug delivery to primary and metastatic brain tumors: challenges and opportunities S Talele, AS Mohammad, JA Schulz, B Bauer, AMS Hartz, JN Sarkaria, ... Drug delivery to the brain: physiological concepts, methodologies and …, 2022 | 3 | 2022 |
| Hepatocyte uptake and loss assay (HUpLA): proof-of-concept of an all-in-one system for measuring hepatic influx, egress, and metabolic clearance based on the extended clearance … JAS Pauly, E Sande, M Feng, YT Wang, DM Stresser, JC Kalvass Drug Metab Dispos 52, 2024 | 2 | 2024 |
| Assumptions underlying hepatic clearance models: recognizing the influence of saturable protein binding on driving force concentration and discrimination between models of … JAS Pauly, J Wang, CJ Phipps, JC Kalvass Drug Metabolism and Disposition 51 (8), 1046-1052, 2023 | 2 | 2023 |
| CADD-16. DUAL PI3K/Akt INHIBITION TO OVERCOME THE P-gp/BCRP DRUG EFFLUX SYSTEM FOR IMPROVED DRUG DELIVERY IN GLIOBLASTOMA THERAPY A Hartz, J Schulz, B Sokola, B Bauer Neuro-oncology 20 (Suppl 6), vi279, 2018 | 1 | 2018 |
| Clearance prediction with three novel plated human hepatocyte models compared to conventional suspension assays: Assessment with 50 compounds and multiple donors DA Kukla, JAS Pauly, PR Lesniak, E Sande, YT Wang, JC Kalvass, ... Drug Metabolism and Disposition 53 (2), 100032, 2025 | | 2025 |
| Proof of Concept of an All-in-One System for Measuring Hepatic Influx, Egress, and Metabolic Clearance Based on the Extended Clearance Concept JAS Pauly, E Sande, M Feng, YT Wang, DM Stresser, JC Kalvass Drug Metabolism and Disposition 52 (10), 1048-1059, 2024 | | 2024 |
| Improving in vitro clearance assay performance and prediction accuracy with advanced human hepatocyte models for highly stable RO5 and BRO5 compounds D Kukla, J Pauly, C Kalvass, G Jenkins, D Stresser Drug Metabolism and Pharmacokinetics 55, 100820, 2024 | | 2024 |
| 442 Repurposing FDA-approved PI3K/Akt Inhibitors to Improve Anti-Cancer Drug Brain Uptake in Glioblastoma Resection Models L Rodgers, Y Tega, JA Schulz, AMS Hartz, B Bauer Journal of Clinical and Translational Science 6 (s1), 87-87, 2022 | | 2022 |
| ABC Transporters in Glioblastoma: Anticancer Drug Transport and Transporter Regulation at the Blood-brain Barrier JA Schulz | | 2021 |
Bjoern BauerUniversity of Kentuckyuky.edu üzerinde doğrulanmış e-posta adresine sahip
